Duration of Androgen Suppression in the Treatment of Prostate Cancer

2009959 citationsJournal Articlebronze Open Access

Authors

M. Bolla · Centre Hospitalier Universitaire de Grenoble

Theodorus M. de Reijke · Academic Medical Center

Geertjan van Tienhoven · Academic Medical Center

Alphonsus C. M. van den Bergh · University of Groningen

Jorg R. Oddens · Jeroen Bosch Ziekenhuis

Philip Poortmans · Instituut Verbeeten

Eliahu Gez

Abstract

The combination of radiotherapy plus 6 months of androgen suppression provides inferior survival as compared with radiotherapy plus 3 years of androgen suppression in the treatment of locally advanced prostate cancer. (ClinicalTrials.gov number, NCT00003026.)

Topics & Keywords

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Cancer, Lipids, and Metabolism

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 360, Issue 24, pp. 2516-2527

DOI: 10.1056/nejmoa0810095

Field-Weighted Citation Impact: 66.68